ArticleGlobalization and health2020
Non-communicable disease governance in the era of the sustainable development goals: a qualitative analysis of food industry framing in WHO consultations.
Article in Globalization and health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- The impact of an integrated exercise and dietary counseling program on physiological biomarkers in sedentary bank employees: a randomized control trial.Scientific reports · 2025Trial
- Commercial interests in health policy dialogues: a qualitative content analysis of NEDLAC's engagement with South Africa's Health Promotion Levy.Globalization and health · 2026Article
- Constructing and contesting industry's role in multistakeholder governance: a qualitative analysis of responses to WHO consultations.Globalization and health · 2025Article
- Corporate activities that influence population health: a scoping review and qualitative synthesis to develop the HEALTH-CORP typology.Globalization and health · 2024Article
- Building a Systems Map: Applying Systems Thinking to Unhealthy Commodity Industry Influence on Public Health Policy.International journal of health policy and management · 2024Article
- The role of the private sector in noncommunicable disease prevention and management in low- and middle-income countries: a series of systematic reviews and thematic syntheses.International journal of qualitative studies on health and well-being · 2023Review
- Understanding the corporate political activity of the ultra - processed food industry in East Asia: a Philippines case study.Globalization and health · 2023Article
- The Way Forward on Nutrition in Food Systems Transformation: A Response to the Recent Commentaries.International journal of health policy and management · 2022Article
- 'Choice should be made through… educated decisions not regressive dictates': discursive framings of a proposed 'sugar tax' in Bermuda: analysis of submissions to a government consultation.Globalization and health · 2022Article
- A Framing Analysis of Consultation Submissions on the WHO Global Strategy to Reduce the Harmful Use of Alcohol: Values and Interests.International journal of health policy and management · 2022Article
- Lacking Clarity or Strategic Ambiguity? Comment on "Competing Frames in Global Health Governance: An Analysis of Stakeholder Influence on the Political Declaration on Non-communicable Diseases".International journal of health policy and management · 2022Article
- Baby food industry interference with infant feeding international regulation-A case study on the standard for follow-up formula.Frontiers in public health · 2022Article
- Escaping the Red Queen: Health as a corporate food marketing strategy.SSM - population health · 2021Article
- What You Don't Know About the Codex Can Hurt You: How Trade Policy Trumps Global Health Governance in Infant and Young Child Nutrition.International journal of health policy and management · 2021Article
- "Part of the Solution": Food Corporation Strategies for Regulatory Capture and Legitimacy.International journal of health policy and management · 2021Review
- Article
- Corporate political activity in the context of unhealthy food advertising restrictions across Transport for London: A qualitative case study.PLoS medicine · 2021Article
- Review
- Commercial use of evidence in public health policy: a critical assessment of food industry submissions to global-level consultations on non-communicable disease prevention.BMJ global health · 2021Article
- Conceptualizing the commercial determinants of dietary behaviors associated with obesity: A systematic review using principles from critical interpretative synthesis.Obesity science & practice · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundThe UN system's shift towards multistakeholder governance, now embedded in the Sustainable Development Goals (SDGs), invites a broad range of actors, including the private sector, to the policymaking table. Although the tobacco industry is formally excluded from engagement, this approach provides opportunities for other unhealthy commodity industries to influence the World Health Organization's (WHO's) non-communicable disease (NCD) agenda. Focusing on the food industry, this research maps which actors engaged with WHO consultations, and critically examines actors' policy and governance preferences as well as the framing they employ to promote these preferences in the global context.
methodsAll written responses from food industry actors to publicly available NCD-relevant WHO consultations held between September 2015 and September 2018 were identified, totalling forty-five responses across five consultations. A qualitative frame analysis was conducted to identify policy positions expressed by respondents, as well as arguments and frames used to do so.
resultsThough no individual companies responded to the consultations, the majority of participating business associations had some of the largest multinational food corporations as members. Respondents overarchingly promoted non-statutory approaches and opposed statutory regulation and conflict of interest safeguards. To this purpose, they framed the food industry as a legitimate and necessary partner in policymaking, differentiating themselves from the tobacco industry and referencing a history of successful collaboration, while also invoking multistakeholder norms and good governance principles to portray collaboration as required. Respondents contrasted this with the limits of WHO's mandate, portraying it as out of step with the SDGs and framing NCD decision-making as a matter of national sovereignty.
conclusionWe observed that the UN's call for partnerships to support the SDGs is invoked to defend corporate access to NCD policy. This highlights the need for more cautious approaches which are mindful of the commercial determinants of health. Systematic opposition to regulation and to governance approaches which may compromise commercial actors' insider role in global health by food industry actors shown here, and the strategic use of the Sustainable Development agenda to this purpose, raises questions about the value of collaboration from the perspective of international health agencies such as WHO.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.